Search Results

Mapping genomic loci implicates genes and synaptic biology in schizophrenia.

• Authors : Trubetskoy V; Pardiñas AF ...

Subjects: Genome-Wide Association Study* ; Schizophrenia*/Schizophrenia*/Schizophrenia*/genetics; Alleles

• Source: Nature [Nature] 2022 Apr; Vol. 604 (7906), pp. 502-508. Date of Electronic Publication: 2022 Apr 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia.

• Authors : Zhou DY; Yunnan Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.; Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, Yunnan, China.

Subjects: Schizophrenia* ; Cation Transport Proteins*/Cation Transport Proteins*/Cation Transport Proteins*/genetics ; Cation Transport Proteins*/Cation Transport Proteins*/Cation Transport Proteins*/metabolism

• Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 Jan; Vol. 49 (2), pp. 433-442. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review.

• Authors : Smessaert S; University Psychiatric Center Katholieke Universiteit Leuven, Leuvensesteenweg 517, 3070, Kortenberg, Belgium. .; Detraux J

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced

• Source: CNS drugs [CNS Drugs] 2024 Feb; Vol. 38 (2), pp. 105-123. Date of Electronic Publication: 2024 Jan 18.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet

Record details

A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance.

• Authors : Yang K; Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Longo L

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Psychotic Disorders*/Psychotic Disorders*/Psychotic Disorders*/diagnosis ; Psychotic Disorders*/Psychotic Disorders*/Psychotic Disorders*/drug therapy

• Source: Molecular psychiatry [Mol Psychiatry] 2022 Feb; Vol. 27 (2), pp. 1184-1191. Date of Electronic Publication: 2021 Oct 12.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

Exploring the Effectiveness of Group Cognitive Stimulation Training in People With Schizophrenia: A Randomized Controlled Trial.

• Authors : Chang CC; PhD, RN, Assistant Professor, College of Nursing, Chang Gung University of Science and Technology, Taiwan.; Wu HS

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/complications ; Schizophrenia*/Schizophrenia*/Schizophrenia*/therapy ; Cognitive Dysfunction*/Cognitive Dysfunction*/Cognitive Dysfunction*/therapy

• Source: The journal of nursing research : JNR [J Nurs Res] 2023 Oct 01; Vol. 31 (5), pp. e291. Date of Electronic Publication: 2023 Oct 01.Publisher: Lippincott Williams & Wilkins Country of Publication: China (Republic : 1949- ) NLM ID: 101128757 Publication Model: Electronic Cited Medium:

Record details

How Andrew Yang's Personal Experience With Autism Is Shaping His Policy Proposals

• Source: All Things Considered. January 2, 2020

Record details

Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow.

• Authors : Hare SM; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. .; Adhikari BM

Subjects: Kynurenine* ; Schizophrenia*; Rats

• Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2023 Oct; Vol. 48 (11), pp. 1594-1601. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A machine learning model for predicting blood concentration of quetiapine in patients with schizophrenia and depression based on real-world data.

• Authors : Hao Y; Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, China.; The Technology Innovation Center for Artificial Intelligence in Clinical Pharmacy of Hebei Province, The First Hospital of Hebei Medical University, Shijiazhuang, China.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use; Humans

• Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Sep; Vol. 89 (9), pp. 2714-2725. Date of Electronic Publication: 2023 May 07.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Multicenter Study.

• Authors : Wang D; Wei N; Hu F

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

• Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2022 Jul-Aug 01; Vol. 42 (4), pp. 383-390. Date of Electronic Publication: 2022 Jun 11.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Up-Regulation of S100 Gene Family in Brain Samples of a Subgroup of Individuals with Schizophrenia: Meta-analysis.

• Authors : Shamir A; The Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.; Yitzhaky A

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/genetics; Humans ; Up-Regulation

• Source: Neuromolecular medicine [Neuromolecular Med] 2023 Sep; Vol. 25 (3), pp. 388-401. Date of Electronic Publication: 2023 Apr 02.Publisher: Humana Press Country of Publication: United States NLM ID: 101135365 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Identification of genetic features that are associated with amplitude of low-frequency fluctuation changes in schizophrenia using omics analysis.

• Authors : Luo W; College of Mathematics and Informatics, South China Agricultural University, Guangzhou, China.; Pazhou Lab, Guangzhou, China.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/genetics ; Schizophrenia*/Schizophrenia*/Schizophrenia*/metabolism; Humans

• Source: Journal of neuroscience research [J Neurosci Res] 2024 Feb; Vol. 102 (2), pp. e25297.Publisher: Wiley Interscience Country of Publication: United States NLM ID: 7600111 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Phosphodiesterase inhibitors in psychiatric disorders.

• Authors : Sadeghi MA; Toxicology Research Center, AJA University of Medical Sciences, Tehran, Iran.; Department of Pharmacology, School of Medicine, AJA University of Medical Sciences, Tehran, Iran.

Subjects: Mental Disorders*/Mental Disorders*/Mental Disorders*/drug therapy ; Phosphodiesterase 4 Inhibitors* ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

• Source: Psychopharmacology [Psychopharmacology (Berl)] 2023 Jun; Vol. 240 (6), pp. 1201-1219. Date of Electronic Publication: 2023 Apr 15.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Shared and distinct abnormalities of brain magnetization transfer ratio in schizophrenia and major depressive disorder: a comparative voxel-based meta-analysis.

• Authors : Lan H; Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.; Suo X

Subjects: Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/pathology; Humans

• Source: Chinese medical journal [Chin Med J (Engl)] 2023 Dec 05; Vol. 136 (23), pp. 2824-2833. Date of Electronic Publication: 2023 Dec 05.Publisher: Chinese Medical Association ; produced by Wolters Kluwer Country of Publication: China NLM ID: 7513795 Publication Model: Electronic Cited

Record details

Significance of an altered lncRNA landscape in schizophrenia and cognition: clues from a case-control association study.

• Authors : Mukhopadhyay A; Department of Genetics, University of Delhi South Campus, Benito Juarez Marg, New Delhi, 110021, India.; Deshpande SN

Subjects: RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; Schizophrenia*/Schizophrenia*/Schizophrenia*/complications ; Tardive Dyskinesia*/Tardive Dyskinesia*/Tardive Dyskinesia*/complications

• Source: European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2023 Dec; Vol. 273 (8), pp. 1677-1691. Date of Electronic Publication: 2023 Apr 03.Publisher: Springer International Country of Publication: Germany NLM ID: 9103030 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Allele-specific DNA methylation maps in monozygotic twins discordant for psychiatric disorders reveal that disease-associated switching at the EIPR1 regulatory loci modulates neural function.

• Authors : Li Q; Department of Medical Genetics, School of Basic Medical Sciences, and Guangdong Technology and Engineering Research Center for Molecular Diagnostics of Human Genetic Diseases, Southern Medical University, Guangzhou, Guangdong, China.; Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, and Guangdong Province Key Laboratory of Psychiatric Disorders, Southern Medical University, Guangzhou, Guangdong, China.

Subjects: DNA Methylation*/DNA Methylation*/DNA Methylation*/genetics ; Schizophrenia*/Schizophrenia*/Schizophrenia*/genetics; Nuclear Proteins/Nuclear Proteins/Nuclear Proteins/*genetics

• Source: Molecular psychiatry [Mol Psychiatry] 2021 Nov; Vol. 26 (11), pp. 6630-6642. Date of Electronic Publication: 2021 May 07.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

• Authors : van Erp TGM; Walton E ...

Subjects: Brain/Brain/Brain/*pathology ; Schizophrenia/Schizophrenia/Schizophrenia/*diagnostic imaging ; Schizophrenia/Schizophrenia/Schizophrenia/*pathology

• Source: Biological psychiatry [Biol Psychiatry] 2018 Nov 01; Vol. 84 (9), pp. 644-654. Date of Electronic Publication: 2018 May 14.Publisher: Elsevier Country of Publication: United States NLM ID: 0213264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.

• Authors : Kelly S; Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.; Harvard Medical School, Boston, MA, USA.

Subjects: Schizophrenia/Schizophrenia/Schizophrenia/*diagnostic imaging ; Schizophrenia/Schizophrenia/Schizophrenia/*physiopathology ; White Matter/White Matter/White Matter/*ultrastructure

• Source: Molecular psychiatry [Mol Psychiatry] 2018 May; Vol. 23 (5), pp. 1261-1269. Date of Electronic Publication: 2017 Oct 17.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia.

• Authors : Masumo Y; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba.; Department of Psychiatry, Naoki-kai Isogaya Hospital, Ichihara.

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis

• Source: International clinical psychopharmacology [Int Clin Psychopharmacol] 2023 Mar 01; Vol. 38 (2), pp. 102-109. Date of Electronic Publication: 2022 Nov 11.Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 8609061 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data.

• Authors : Ding J; Zhang Y; The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xi'an, China.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*; Humans

• Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2022 Nov-Dec 01; Vol. 42 (6), pp. 552-559. Date of Electronic Publication: 2022 Oct 25.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Sex-differential associations between cognitive impairments and white matter abnormalities in first episode and drug-naïve schizophrenia.

• Authors : Yang M; The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for NeuroInformation, University of Electronic Science and Technology of China, Chengdu, China.; School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.

Subjects: Cognitive Dysfunction*/Cognitive Dysfunction*/Cognitive Dysfunction*/diagnostic imaging ; Pharmaceutical Preparations* ; Schizophrenia*/Schizophrenia*/Schizophrenia*/complications

• Source: Early intervention in psychiatry [Early Interv Psychiatry] 2021 Oct; Vol. 15 (5), pp. 1179-1187. Date of Electronic Publication: 2020 Oct 15.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 101320027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The correlation between dynamic functional architecture and response to electroconvulsive therapy combined with antipsychotics in schizophrenia.

• Authors : Gong J; Engineering Research Center of Molecular and Neuro Imaging of the Ministry of Education, School of Life Sciences and Technology, Xidian University, Xi'an, China.; Cui LB

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Electroconvulsive Therapy*/Electroconvulsive Therapy*/Electroconvulsive Therapy*/methods ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

• Source: The European journal of neuroscience [Eur J Neurosci] 2022 Apr; Vol. 55 (8), pp. 2024-2036. Date of Electronic Publication: 2022 Apr 18.Publisher: Wiley-Blackwell Country of Publication: France NLM ID: 8918110 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Relative importance of speech and voice features in the classification of schizophrenia and depression.

• Authors : Berardi M; Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany. .; Brosch K

Subjects: Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/diagnosis ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis; Humans

• Source: Translational psychiatry [Transl Psychiatry] 2023 Sep 19; Vol. 13 (1), pp. 298. Date of Electronic Publication: 2023 Sep 19.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Synaptic dysfunction in schizophrenia.

• Authors : Mısır E; Department of Psychiatry, Baskent University Faculty of Medicine, Ankara, Turkey.; Department of Interdisciplinary Neuroscience, Ankara University, Ankara, Turkey.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/metabolism ; Antipsychotic Agents*

• Source: Synapse (New York, N.Y.) [Synapse] 2023 Sep; Vol. 77 (5), pp. e22276. Date of Electronic Publication: 2023 May 21.Publisher: Country of Publication: United States NLM ID: 8806914 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2396

Record details

Clinical anatomy of the precuneus and pathogenesis of the schizophrenia.

• Authors : Messina A; Department of Clinical and Experimental Medicine, Psychiatry Unit, University of Catania, Catania, Italy. .; Cuccì G

Subjects: Magnetic Resonance Imaging* ; Schizophrenia*/Schizophrenia*/Schizophrenia*/pathology; Humans

• Source: Anatomical science international [Anat Sci Int] 2023 Sep; Vol. 98 (4), pp. 473-481. Date of Electronic Publication: 2023 Jun 20.Publisher: Springer Japan Country of Publication: Japan NLM ID: 101154140 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A meta-analysis and systematic review of single vs. multimodal neuroimaging techniques in the classification of psychosis.

• Authors : Porter A; Department of Psychology, Northwestern University, Evanston, IL, USA. .; Fei S

Subjects: Psychotic Disorders*/Psychotic Disorders*/Psychotic Disorders*/diagnostic imaging ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging; Humans

• Source: Molecular psychiatry [Mol Psychiatry] 2023 Aug; Vol. 28 (8), pp. 3278-3292. Date of Electronic Publication: 2023 Aug 10.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial.

• Authors : Roeske MJ; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA. .; McHugo M

Subjects: Piracetam*/Piracetam*/Piracetam*/therapeutic use ; Piracetam*/Piracetam*/Piracetam*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging

• Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 Mar; Vol. 49 (4), pp. 681-689. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Previous psychiatric hospitalizations as risk factors for single and multiple future alcohol-related hospitalizations in patients with alcohol use disorders.

• Authors : Manca F; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.; Lewsey J

Subjects: Alcoholism*/Alcoholism*/Alcoholism*/epidemiology ; Alcoholism*/Alcoholism*/Alcoholism*/psychology ; Schizophrenia*

• Source: Addiction (Abingdon, England) [Addiction] 2024 Feb; Vol. 119 (2), pp. 291-300. Date of Electronic Publication: 2023 Sep 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example.

• Authors : Nisha Aji K; Douglas Research Centre, Clinical and Translational Sciences Lab, Montreal, QC, Canada.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.

Subjects: Monoamine Oxidase*/Monoamine Oxidase*/Monoamine Oxidase*/drug effects ; Monoamine Oxidase*/Monoamine Oxidase*/Monoamine Oxidase*/metabolism ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging

• Source: Advances in neurobiology [Adv Neurobiol] 2023; Vol. 30, pp. 335-362.Publisher: Springer Country of Publication: United States NLM ID: 101571545 Publication Model: Print Cited Medium: Print ISSN: 2190-5215 (Print)

Record details

Fingolimod ameliorates schizophrenia-like cognitive impairments induced by phencyclidine in male rats.

• Authors : Yu X; Department of Neurobiology, Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.; NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Science Center for Brain Science and Brain-machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/chemically induced ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/metabolism

• Source: British journal of pharmacology [Br J Pharmacol] 2023 Jan; Vol. 180 (2), pp. 161-173. Date of Electronic Publication: 2022 Oct 05.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381

Record details

Cognitive Dysfunction as a Risk Factor for Psychosis.

• Authors : Karcher NR; Department of Psychiatry, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA. .; Merchant J

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis ; Psychotic Disorders* ; Cognitive Dysfunction*

• Source: Current topics in behavioral neurosciences [Curr Top Behav Neurosci] 2023; Vol. 63, pp. 173-203.Publisher: Springer Country of Publication: Germany NLM ID: 101535383 Publication Model: Print Cited Medium: Print ISSN: 1866-3370 (Print)

Record details

Aberrant maturation and connectivity of prefrontal cortex in schizophrenia-contribution of NMDA receptor development and hypofunction.

• Authors : Gao WJ; Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, PA, 19129, USA. .; Yang SS

Subjects: Receptors, N-Methyl-D-Aspartate*/Receptors, N-Methyl-D-Aspartate*/Receptors, N-Methyl-D-Aspartate*/metabolism ; Schizophrenia*/Schizophrenia*/Schizophrenia*/genetics; Humans

• Source: Molecular psychiatry [Mol Psychiatry] 2022 Jan; Vol. 27 (1), pp. 731-743. Date of Electronic Publication: 2021 Jun 23.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

Genome-wide association study of cerebellar volume provides insights into heritable mechanisms underlying brain development and mental health.

• Authors : Tissink E; Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, 1081 HV, Amsterdam, The Netherlands.; de Lange SC

Subjects: Genome-Wide Association Study*/Genome-Wide Association Study*/Genome-Wide Association Study*/methods ; Schizophrenia*/Schizophrenia*/Schizophrenia*/genetics; Brain

• Source: Communications biology [Commun Biol] 2022 Jul 16; Vol. 5 (1), pp. 710. Date of Electronic Publication: 2022 Jul 16.Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia.

• Authors : Francis MM; Department of Psychiatry, Indiana University School of Medicine, 355 W. 16th St., Suite 4800, Indianapolis, IN, 46202, USA. .; Prevention and Recovery Center for Early Psychosis, Outpatient Care Center, Eskenazi Health Midtown Community Mental Health Center, 720 Eskenazi Ave, Outpatient Care Center, Lower Level, Indianapolis, IN, 46202, USA. .

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; White Matter*/White Matter*/White Matter*/diagnostic imaging

• Source: Brain imaging and behavior [Brain Imaging Behav] 2021 Aug; Vol. 15 (4), pp. 1802-1814.Publisher: Springer Country of Publication: United States NLM ID: 101300405 Publication Model: Print Cited Medium: Internet ISSN: 1931-7565

Record details

Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders.

• Authors : Blokland GAM; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium

Subjects: Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/genetics ; Psychotic Disorders*/Psychotic Disorders*/Psychotic Disorders*/genetics ; Sex Characteristics*

• Source: Biological psychiatry [Biol Psychiatry] 2022 Jan 01; Vol. 91 (1), pp. 102-117. Date of Electronic Publication: 2021 Mar 23.Publisher: Elsevier Country of Publication: United States NLM ID: 0213264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.

• Authors : Xiang YQ; National Clinical Research Center for Mental Disorders, Beijing, China & Center of Depression, Beijing Institute for Brain Disorders, China; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Minocycline/Minocycline/Minocycline/*therapeutic use ; Schizophrenia/Schizophrenia/Schizophrenia/*drug therapy

• Source: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2017 Jan; Vol. 27 (1), pp. 8-18. Date of Electronic Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Impaired extinction of operant cocaine in a genetic mouse model of schizophrenia risk.

• Authors : Chesworth R; School of Medicine, Western Sydney University, Campbelltown, NSW, Australia. .; Visini G

Subjects: Cocaine*/Cocaine*/Cocaine*/pharmacology ; Schizophrenia*/Schizophrenia*/Schizophrenia*/genetics ; Cocaine-Related Disorders*/Cocaine-Related Disorders*/Cocaine-Related Disorders*/genetics

• Source: Psychopharmacology [Psychopharmacology (Berl)] 2023 Jul; Vol. 240 (7), pp. 1531-1546. Date of Electronic Publication: 2023 May 26.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group.

• Authors : Bauer A; Sunovion Pharmaceuticals, Marlborough, MA, 01752, USA.; Berben P

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy; Humans

• Source: Pharmaceutical research [Pharm Res] 2023 Jul; Vol. 40 (7), pp. 1601-1631. Date of Electronic Publication: 2023 Feb 22.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium:

Record details

Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment.

• Authors : de Bartolomeis A; Section of Psychiatry, Laboratory of Molecular and Translational Psychiatry, Unit of Treatment-Resistant Psychiatric Disorders, Department of Neuroscience, Reproductive Sciences and Odontostomatology University of Naples 'Federico II', School of Medicine, Via Pansini 5, 80131, Naples, Italy. .; De Simone G

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/metabolism; Humans ; Animals

• Source: Molecular psychiatry [Mol Psychiatry] 2023 Jul; Vol. 28 (7), pp. 2811-2825. Date of Electronic Publication: 2023 Apr 21.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

History of suicide attempt associated with amygdala and hippocampus changes among individuals with schizophrenia.

• Authors : Yin Y; Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, 100096, People's Republic of China.; Tong J

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging; Humans ; Suicide, Attempted

• Source: European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2023 Jun; Vol. 273 (4), pp. 921-930. Date of Electronic Publication: 2023 Feb 14.Publisher: Springer International Country of Publication: Germany NLM ID: 9103030 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Mechanism and treatments of antipsychotic-induced weight gain.

• Authors : Ye W; School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.; Xing J

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Metabolic Syndrome*/Metabolic Syndrome*/Metabolic Syndrome*/chemically induced

• Source: International journal of obesity (2005) [Int J Obes (Lond)] 2023 Jun; Vol. 47 (6), pp. 423-433. Date of Electronic Publication: 2023 Mar 23.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101256108 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Abnormal Structural Network Communication Reflects Cognitive Deficits in Schizophrenia.

• Authors : Zorlu N; Department of Psychiatry, Katip Celebi University, Ataturk Education and Research Hospital, Izmir, Turkey. .; Bayrakçı A

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging ; Cognition Disorders*/Cognition Disorders*/Cognition Disorders*/complications ; Cognition Disorders*/Cognition Disorders*/Cognition Disorders*/pathology

• Source: Brain topography [Brain Topogr] 2023 May; Vol. 36 (3), pp. 294-304. Date of Electronic Publication: 2023 Mar 27.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8903034 Publication Model: Print-Electronic Cited Medium:

Record details

Baseline symptom-related white matter tracts predict individualized treatment response to 12-week antipsychotic monotherapies in first-episode schizophrenia.

• Authors : Chen Y; Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.; Hope Recovery and Rehabilitation Center, West China Hospital of Sichuan University, Chengdu, China.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; White Matter*/White Matter*/White Matter*/diagnostic imaging

• Source: Translational psychiatry [Transl Psychiatry] 2024 Jan 13; Vol. 14 (1), pp. 23. Date of Electronic Publication: 2024 Jan 13.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.

• Authors : Seitz-Holland J; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. .; Cetin-Karayumak S

Subjects: Schizophrenia* ; White Matter*/White Matter*/White Matter*/diagnostic imaging; Anisotropy

• Source: Molecular psychiatry [Mol Psychiatry] 2021 Sep; Vol. 26 (9), pp. 5357-5370. Date of Electronic Publication: 2021 Jan 22.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia.

• Authors : Morris G; IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.; Sominsky L

Subjects: Depressive Disorder, Major* ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Schizophrenia*

• Source: Molecular neurobiology [Mol Neurobiol] 2022 Jun; Vol. 59 (6), pp. 3485-3503. Date of Electronic Publication: 2022 Mar 26.Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The colors of our brain: an integrated approach for dimensionality reduction and explainability in fMRI through color coding (i-ECO).

• Authors : Tarchi L; Psychiatry Unit, Department of Health Sciences, University of Florence, viale della Maternità, Padiglione 8b, AOU Careggi, Firenze, Florence, FI, 50134, Italy. .; Damiani S

Subjects: Magnetic Resonance Imaging*/Magnetic Resonance Imaging*/Magnetic Resonance Imaging*/methods ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging; Brain/Brain/Brain/diagnostic imaging

• Source: Brain imaging and behavior [Brain Imaging Behav] 2022 Jun; Vol. 16 (3), pp. 977-990. Date of Electronic Publication: 2021 Oct 24.Publisher: Springer Country of Publication: United States NLM ID: 101300405 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders.

• Authors : Bradlow RCJ; Turning Point, Eastern Health, Richmond, VIC, Australia.; Berk M

Subjects: Bipolar Disorder*/Bipolar Disorder*/Bipolar Disorder*/drug therapy ; Obsessive-Compulsive Disorder*/Obsessive-Compulsive Disorder*/Obsessive-Compulsive Disorder*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

• Source: CNS drugs [CNS Drugs] 2022 May; Vol. 36 (5), pp. 451-482. Date of Electronic Publication: 2022 Mar 22.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Frequency-specific alternations in the moment-to-moment BOLD signals variability in schizophrenia.

• Authors : Zhang Y; School of Psychology, Chengdu Normal University, No.99, East section, Haike Road, Chengdu, People's Republic of China, 611130. .; Yang R

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnostic imaging; Brain/Brain/Brain/diagnostic imaging ; Humans

• Source: Brain imaging and behavior [Brain Imaging Behav] 2021 Feb; Vol. 15 (1), pp. 68-75.Publisher: Springer Country of Publication: United States NLM ID: 101300405 Publication Model: Print Cited Medium: Internet ISSN: 1931-7565

Record details

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta-analysis of variance.

• Authors : Martins D; Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Paduraru M

Subjects: Autism Spectrum Disorder*/Autism Spectrum Disorder*/Autism Spectrum Disorder*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy; Administration, Intranasal

• Source: British journal of pharmacology [Br J Pharmacol] 2022 Apr; Vol. 179 (8), pp. 1525-1543. Date of Electronic Publication: 2021 May 06.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381

Record details

A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia.

• Authors : McGuinness AJ; The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Food & Mood Centre, School of Medicine and Barwon Health, Deakin University, Geelong, VIC, Australia.; Davis JA

Subjects: Bipolar Disorder* ; Depressive Disorder, Major* ; Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/physiology

• Source: Molecular psychiatry [Mol Psychiatry] 2022 Apr; Vol. 27 (4), pp. 1920-1935. Date of Electronic Publication: 2022 Feb 22.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

Diagnostic progression to schizophrenia in 35,255 patients with obsessive-compulsive disorder: a longitudinal follow-up study.

• Authors : Chen MH; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Department of Psychiatry, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/complications ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis ; Schizophrenia*/Schizophrenia*/Schizophrenia*/epidemiology

• Source: European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2023 Apr; Vol. 273 (3), pp. 541-551. Date of Electronic Publication: 2022 Mar 24.Publisher: Springer International Country of Publication: Germany NLM ID: 9103030 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details